SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-099544
Filing Date
2011-04-15
Accepted
2011-04-15 16:17:43
Documents
2
Period of Report
2011-05-18
Effectiveness Date
2011-04-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE & PROXY STATEMENT ddef14a.htm DEF 14A 618018
2 GRAPHIC g147599g12p10.jpg GRAPHIC 11460
  Complete submission text file 0001193125-11-099544.txt   635045
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51462 | Film No.: 11762900
SIC: 2836 Biological Products, (No Diagnostic Substances)